- Home
- CLRB vs SANW Comparison
CLRB vs SANW Comparison
Compare CLRB & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- SANW
- Stock Information
- Founded
- CLRB 2002
- SANW 1980
- Country
- CLRB United States
- SANW United States
- Employees
- CLRB N/A
- SANW N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- SANW Farming/Seeds/Milling
- Sector
- CLRB Health Care
- SANW Consumer Staples
- Exchange
- CLRB Nasdaq
- SANW Nasdaq
- Market Cap
- CLRB 12.5M
- SANW 11.6M
- IPO Year
- CLRB N/A
- SANW 2010
- Fundamental
- Price
- CLRB $0.36
- SANW $5.48
- Analyst Decision
- CLRB Hold
- SANW Strong Buy
- Analyst Count
- CLRB 2
- SANW 1
- Target Price
- CLRB N/A
- SANW $25.00
- AVG Volume (30 Days)
- CLRB 34.3M
- SANW 6.3K
- Earning Date
- CLRB 05-13-2025
- SANW 05-15-2025
- Dividend Yield
- CLRB N/A
- SANW N/A
- EPS Growth
- CLRB N/A
- SANW N/A
- EPS
- CLRB N/A
- SANW N/A
- Revenue
- CLRB N/A
- SANW $54,993,808.00
- Revenue This Year
- CLRB N/A
- SANW N/A
- Revenue Next Year
- CLRB N/A
- SANW $14.25
- P/E Ratio
- CLRB N/A
- SANW N/A
- Revenue Growth
- CLRB N/A
- SANW 6.91
- 52 Week Low
- CLRB $0.22
- SANW $2.10
- 52 Week High
- CLRB $3.42
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- CLRB 61.13
- SANW 49.38
- Support Level
- CLRB $0.23
- SANW $5.36
- Resistance Level
- CLRB $0.69
- SANW $5.88
- Average True Range (ATR)
- CLRB 0.05
- SANW 0.35
- MACD
- CLRB 0.02
- SANW 0.04
- Stochastic Oscillator
- CLRB 26.84
- SANW 57.02
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.